MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.162
NA - Nord America 415
SA - Sud America 386
EU - Europa 195
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 2.183
Nazione #
US - Stati Uniti d'America 388
SG - Singapore 384
BR - Brasile 301
HK - Hong Kong 216
CN - Cina 186
VN - Vietnam 149
KR - Corea 139
AR - Argentina 39
FR - Francia 39
IT - Italia 28
GB - Regno Unito 26
ID - Indonesia 21
DE - Germania 20
EC - Ecuador 16
PL - Polonia 14
BD - Bangladesh 12
IN - India 11
MX - Messico 11
ZA - Sudafrica 10
CA - Canada 9
CO - Colombia 9
PY - Paraguay 9
LT - Lituania 8
UA - Ucraina 8
IQ - Iraq 7
RU - Federazione Russa 7
SE - Svezia 7
ES - Italia 6
EG - Egitto 5
JP - Giappone 5
NL - Olanda 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BE - Belgio 4
CH - Svizzera 4
KG - Kirghizistan 4
TR - Turchia 4
EE - Estonia 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
GH - Ghana 2
GR - Grecia 2
IE - Irlanda 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
RS - Serbia 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.183
Città #
Hong Kong 216
Singapore 150
Seoul 139
Ashburn 83
Chicago 69
Ho Chi Minh City 56
San Jose 45
Beijing 42
Hanoi 29
São Paulo 28
Frankfurt am Main 15
Los Angeles 14
Hillsboro 13
Rio de Janeiro 13
Warsaw 13
Dallas 10
Haiphong 9
Guayaquil 8
London 8
New York 8
Dhaka 7
Da Nang 6
Reston 6
Belo Horizonte 5
Belém 5
Gothenburg 5
Lima 5
Santo André 5
Tashkent 5
Thái Bình 5
Tokyo 5
Baghdad 4
Bishkek 4
Boston 4
Brasília 4
Brussels 4
Curitiba 4
Hải Dương 4
Johannesburg 4
Juiz de Fora 4
Montreal 4
Phoenix 4
Potenza 4
Quito 4
Santa Clara 4
São José dos Campos 4
Zurich 4
Araçatuba 3
Betim 3
Bexley 3
Biên Hòa 3
Bogotá 3
Cairo 3
Can Tho 3
Caxias do Sul 3
Cologna Veneta 3
Florianópolis 3
Limburg an der Lahn 3
Manchester 3
Medellín 3
Montevideo 3
Ninh Bình 3
Orem 3
Ottawa 3
Quilmes 3
Ribeirão Preto 3
Riyadh 3
Rondonópolis 3
St Petersburg 3
São José 3
São José do Rio Preto 3
Tallinn 3
Uberlândia 3
Accra 2
Amsterdam 2
Ankara 2
Araguaína 2
Athens 2
Açailândia 2
Bento Gonçalves 2
Boardman 2
Bologna 2
Bratislava 2
Brooklyn 2
Buenos Aires 2
Camaçari 2
Canaã dos Carajás 2
Cape Town 2
Caruaru 2
Chennai 2
Ciudad del Este 2
Concepción 2
Council Bluffs 2
Cremona 2
Criciúma 2
Córdoba 2
Dubai 2
Dublin 2
Erbil 2
Florence 2
Totale 1.223
Nome #
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 44
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 44
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 43
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 43
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 42
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 42
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 42
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 42
PSD3 downregulation confers protection against fatty liver disease 42
Cross talk between liver and adipose tissue: A new role for PNPLA3? 41
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 41
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 41
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 41
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 40
PNPLA3 I148M polymorphism and progressive liver disease 39
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 39
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 39
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 39
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 38
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation. 38
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 37
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 36
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 36
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 35
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 35
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 34
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 34
Genetic variants in the MTHFR are not associated with fatty liver disease 34
TM6SF2 and PNPLA3: a potential dynamic duo? 34
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 33
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 33
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 33
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 33
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 32
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 32
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 32
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 31
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 31
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 31
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 31
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 31
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 30
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 30
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 30
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 30
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 30
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 30
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 29
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 29
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 29
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 29
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 29
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 29
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 29
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 29
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 28
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 28
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 28
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 28
Statin use and non-alcoholic steatohepatitis in at risk individuals 27
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 27
MBOAT7 is anchored to endomembranes by six transmembrane domains 26
Natural Extracts as Modifiers of Intracellular Lipid Handling 25
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 24
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 23
Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD 23
Validation of Interleukin-32 as a new circulating fatty liver biomarker 22
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 21
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 20
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 18
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism 4
MTARC1 p.A165 ablation reduces hepatocellular carcinoma aggressiveness in vitro and in vivo 2
Totale 2.304
Categoria #
all - tutte 22.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/2025720 19 55 2 9 98 147 76 25 66 38 154 31
2025/20261.517 118 115 299 367 160 26 62 132 152 86 0 0
Totale 2.304